• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术中胰腺实质阳性切缘:在胰管腺癌行胰部分切除术后行全胰切除时是否为真正的切缘阳性指征?

Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?

机构信息

Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

出版信息

Curr Oncol. 2022 Jul 27;29(8):5295-5305. doi: 10.3390/curroncol29080420.

DOI:10.3390/curroncol29080420
PMID:36005158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406454/
Abstract

BACKGROUND

Total pancreatectomy (TP) can be performed in cases with positive resection margin after partial pancreatectomy for pancreatic cancer. However, despite complete removal of the residual pancreatic parenchyme, it is questionable whether an actual R0 resection and favorable survival can be achieved. This study aimed to identify the R0 resection rate and postoperative outcomes, including survival, following completion TP (cTP) performed due to intraoperative positive margin.

METHODS

From 1995 to 2015, 1096 patients with pancreatic ductal adenocarcinoma underwent elective pancreatectomy at the Samsung Medical Center. Among these, 25 patients underwent cTP, which was converted during partial pancreatectomy because of a positive resection margin. To compare survival after R0 resection between the cTP R0 and pancreaticoduodenectomy (PD) R0 cases, propensity score matching was conducted to balance the baseline characteristics.

RESULTS

The R0 rate of cTP performed due to intraoperative positive margin was 84% (21/25). The overall 5-year survival rate (5YSR) in the 25 cTP cases was 8%. There was no difference in the 5YSR between the cTP R0 and cTP R1 groups (9.5% versus 0.0%, = 0.963). However, the 5YSR of the cTP R0 group was significantly lower than that of the PD R0 group (9.5% versus 20.0%, = 0.022). There was no distinct difference in postoperative complications between the cTP R0 versus cTP R1 and cTP R0 versus PD R0 groups.

CONCLUSIONS

In cases with intraoperative positive pancreatic parenchymal resection margin, survival after cTP was not favorable. Careful patient selection is needed to perform cTP in such cases.

摘要

背景

在胰腺癌行部分胰腺切除术后,若切缘阳性可施行全胰腺切除术(TP)。但是,尽管彻底切除了残留胰腺实质,能否实现真正的 R0 切除和有利的生存仍然值得怀疑。本研究旨在确定由于术中阳性切缘而行完成性全胰腺切除术(cTP)的 R0 切除率和术后结局,包括生存。

方法

1995 年至 2015 年,三星医疗中心对 1096 例胰腺导管腺癌患者进行了择期胰腺切除术。其中,25 例患者在部分胰腺切除术中因阳性切缘而改行 cTP。为了比较 cTP 患者 R0 切除术后的生存情况,我们对 cTP R0 与胰十二指肠切除术(PD)R0 病例进行了倾向评分匹配,以平衡基线特征。

结果

因术中阳性切缘而行 cTP 的 R0 率为 84%(21/25)。25 例 cTP 患者的总 5 年生存率(5YSR)为 8%。cTP R0 与 cTP R1 两组间的 5YSR 无差异(9.5%与 0.0%,=0.963)。但是,cTP R0 组的 5YSR 明显低于 PD R0 组(9.5%与 20.0%,=0.022)。cTP R0 组与 cTP R1 组和 cTP R0 组与 PD R0 组间术后并发症无明显差异。

结论

对于术中阳性胰腺实质切缘的病例,cTP 术后的生存情况并不理想。对于此类病例,需要谨慎选择患者进行 cTP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/2b922738f007/curroncol-29-00420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/58b5f30698cc/curroncol-29-00420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/fb0bbc54b3dd/curroncol-29-00420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/2b922738f007/curroncol-29-00420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/58b5f30698cc/curroncol-29-00420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/fb0bbc54b3dd/curroncol-29-00420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae0/9406454/2b922738f007/curroncol-29-00420-g003.jpg

相似文献

1
Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?术中胰腺实质阳性切缘:在胰管腺癌行胰部分切除术后行全胰切除时是否为真正的切缘阳性指征?
Curr Oncol. 2022 Jul 27;29(8):5295-5305. doi: 10.3390/curroncol29080420.
2
Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.当代胰十二指肠切除术治疗胰导管腺癌术中颈部切缘评估的再评价:综述。
JAMA Surg. 2021 May 1;156(5):489-495. doi: 10.1001/jamasurg.2020.5676.
3
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.新辅助治疗时代胰十二指肠切除术治疗胰腺腺癌术中胰腺颈缘评估:来自中央胰腺联盟的多机构分析。
Ann Surg Oncol. 2022 Sep;29(9):6004-6012. doi: 10.1245/s10434-022-11804-w. Epub 2022 May 5.
4
Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.术后并发症对胰腺导管腺癌R0胰腺切除术肿瘤学疗效的有害影响。
J Gastrointest Surg. 2009 May;13(5):907-14. doi: 10.1007/s11605-009-0823-9. Epub 2009 Feb 18.
5
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?胰腺导管腺癌:R1 切除与局部晚期不可切除肿瘤的生存是否存在差异?什么是“真正的”R0 切除?
Ann Surg. 2013 Apr;257(4):731-6. doi: 10.1097/SLA.0b013e318263da2f.
6
Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.左胰腺导管腺癌行胰体尾切除术时切缘状态对复发模式和生存的影响。
J Hepatobiliary Pancreat Sci. 2023 May;30(5):633-643. doi: 10.1002/jhbp.1272. Epub 2022 Nov 30.
7
Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility.在胰腺癌胰十二指肠切除术中,胰腺颈部切缘的冰冻切片效用有限。
Pathology. 2014 Apr;46(3):188-92. doi: 10.1097/PAT.0000000000000072.
8
Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study.在丹麦基于人群的全国性研究中,胰腺导管腺癌患者行全胰和胰远端切除术时切缘无肿瘤残留的预后价值。
Pathol Res Pract. 2024 Feb;254:155077. doi: 10.1016/j.prp.2023.155077. Epub 2024 Jan 3.
9
Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival.远端胆管癌:根治性(R0>1mm)切除可获得良好的生存。
Ann Surg. 2023 Jan 1;277(1):e112-e118. doi: 10.1097/SLA.0000000000005012. Epub 2021 Jun 18.
10
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.腹腔镜与开腹胰腺切除术治疗导管腺癌:胰体尾切除术和胰十二指肠切除术的独立倾向评分匹配分析。
BMC Cancer. 2021 Apr 9;21(1):382. doi: 10.1186/s12885-021-08117-8.

引用本文的文献

1
Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II).术中液体活检作为检测胰腺癌患者胰十二指肠切除术中R1切除的工具:CETUPANC试验(第二部分)
Int J Surg. 2024 Dec 1;110(12):7798-7805. doi: 10.1097/JS9.0000000000002153.
2
Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy.基于计算机断层扫描的影像组学和身体成分分析预测胰十二指肠切除术后临床相关的术后胰瘘
Gland Surg. 2024 Sep 30;13(9):1588-1604. doi: 10.21037/gs-24-167. Epub 2024 Sep 27.

本文引用的文献

1
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.神经周围侵犯对胰头导管腺癌胰十二指肠切除术后疾病复发和生存的影响。
Ann Surg. 2022 Aug 1;276(2):378-385. doi: 10.1097/SLA.0000000000004464. Epub 2020 Oct 19.
2
Surgical Outcomes After Total Pancreatectomy: A High-Volume Center Experience.全胰切除术的手术结果:高容量中心的经验。
Ann Surg Oncol. 2021 Mar;28(3):1543-1551. doi: 10.1245/s10434-020-08957-x. Epub 2020 Aug 5.
3
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.
淋巴管侵犯的转录组特征,胰腺导管腺癌转移的已知危险因素
Cancers (Basel). 2020 Jul 24;12(8):2033. doi: 10.3390/cancers12082033.
4
Total Pancreatectomy: Indications, Advantages and Disadvantages - A Review.全胰切除术:适应症、优缺点——综述
Maedica (Bucur). 2019 Dec;14(4):391-396. doi: 10.26574/maedica.2019.14.4.391.
5
Total Pancreatectomy for Pancreatic Carcinoma: When, Why, and What Are the Outcomes? Results of a Systematic Review.全胰切除术治疗胰腺癌:何时、为何以及结局如何?系统评价的结果。
Pancreas. 2020 Feb;49(2):175-180. doi: 10.1097/MPA.0000000000001474.
6
Local radicality and survival outcome of pancreatic cancer surgery.胰腺癌手术的局部根治性与生存结果
Ann Gastroenterol Surg. 2019 Jul 1;3(5):464-475. doi: 10.1002/ags3.12273. eCollection 2019 Sep.
7
Perioperative outcomes and long-term quality of life after total pancreatectomy.全胰切除术的围手术期结果和长期生活质量。
Br J Surg. 2019 Dec;106(13):1819-1828. doi: 10.1002/bjs.11185. Epub 2019 Jul 8.
8
Chemotherapy for pancreatic cancer.胰腺癌的化疗
Presse Med. 2019 Mar;48(3 Pt 2):e159-e174. doi: 10.1016/j.lpm.2019.02.025. Epub 2019 Mar 15.
9
Optimizing the outcomes of pancreatic cancer surgery.优化胰腺癌手术的结果。
Nat Rev Clin Oncol. 2019 Jan;16(1):11-26. doi: 10.1038/s41571-018-0112-1.
10
Intra-Operative Frozen Section Histology of the Pancreatic Resection Margins and Clinical Outcome of Patients with Adenocarcinoma of the Head of the Pancreas Undergoing Pancreaticoduodenectomy.胰头腺癌行胰十二指肠切除术患者术中冰冻切片胰腺切缘组织学与临床结局
Med Sci Monit. 2018 Jul 15;24:4905-4913. doi: 10.12659/MSM.910279.